Private Quantum Funding Slows, But Deal Flow Stays Lively
Quantum computing funding is entering a more selective phase. Startups in the space have raised USD 1.2 billion (approx. RM5.5 billion) so far this year across seed to growth stages, putting the sector on track to finish below last year’s record USD 4.1 billion (approx. RM18.9 billion) haul. Yet this is not a collapse in startup investment trends. Deal counts remain robust, indicating that investor interest in early quantum tech market opportunities persists even as overall capital volumes retreat from peak levels. The pattern mirrors a classic venture capital slowdown: fewer outsized bets, more scrutiny on technical roadmaps and commercialization paths, but no wholesale retreat. Rather than signaling fading belief in quantum computing funding, the numbers suggest investors are shifting away from momentum-driven rounds toward a more disciplined, milestone-based deployment of capital.
Mega-Rounds Show Capital Still Backs Category Leaders
Despite the pullback from last year’s funding peak, large rounds continue to close for ambitious quantum startups. Photonic recently secured a USD 200 million (approx. RM922 million) financing at a USD 2 billion (approx. RM9.2 billion) valuation, underscoring investor willingness to underwrite capital-intensive hardware and networking plays. QuantWare raised USD 178 million (approx. RM821 million) in a Series B, while Quantum Motion announced a USD 160 million (approx. RM738 million) Series C. These financings show that the venture capital slowdown is not uniform; it is increasingly bifurcated. Capital concentrates in technically differentiated platforms with credible paths to utility-scale systems, even as less mature teams face tougher fundraising conditions. The trend points to a consolidating quantum tech market where leading players pull ahead, smaller startups are pressured to partner or sell, and investors prioritize depth of capability over breadth of portfolio exposure.
Public Quantum Stocks Outperform As Investors Embrace Early Movers
While private funding cools, public markets are rewarding listed quantum computing specialists. The four most prominent pure-play public quantum companies—D-Wave Quantum, IonQ, Quantum Computing and Rigetti Computing—collectively hold around USD 36 billion (approx. RM166 billion) in market capitalization. That level is below their late‑year peak but still many multiples above valuations from just a few years ago. The recent SPAC listing of Xanadu, with a market cap of around USD 5 billion (approx. RM23 billion), further highlights public investor appetite. Public quantum players are also driving sector consolidation through acquisitions, such as IonQ’s USD 1.08 billion (approx. RM4.98 billion) purchase of Oxford Ionics and D-Wave Quantum’s USD 550 million (approx. RM2.5 billion) deal for Quantum Circuits. This divergence—buoyant public valuations alongside more cautious private rounds—suggests that equity markets increasingly view quantum leaders as long-term platform bets rather than speculative science projects.
Quantinuum’s IPO And The Maturing Quantum Investment Cycle
The upcoming listing of Quantinuum could become a defining moment for quantum computing funding. The company, a full‑stack platform provider majority owned by Honeywell, last raised capital at a USD 10 billion (approx. RM46.1 billion) pre‑money valuation. Expectations are that its public valuation will land substantially higher, reinforcing the message that public investors are prepared to pay premium prices for category leaders. For venture backers, this marks a transition from a market dominated by private mega‑rounds to one where liquidity is increasingly provided by stock exchanges and strategic acquirers. The shift reflects changing risk appetite: public investors are betting on a handful of scaled platforms, while private capital becomes more selective, favoring startups that can plug into these ecosystems. Together, these dynamics indicate a maturing quantum tech market, where consolidation, exits and disciplined capital allocation start to replace early‑stage exuberance.